Location-Skin melanoma Posts on Medivizor
Navigation Menu

Location-Skin melanoma Posts on Medivizor

Is ultrasound surveillance of lymph nodes safe in patients with medium-risk melanoma?

Posted by on Mar 22, 2019 in Melanoma | 0 comments

In a nutshell This study wanted to find out if performing ultrasounds and performing clinical exams is a safe option to catch cancer that has spread to the lymph nodes in patients with melanoma. The study found that a significant number of tumors were found in lymph nodes by performing this type of surveillance. Some background The most common...

Read More

TVEC therapy for patients with advanced stage melanoma

Posted by on Mar 5, 2019 in Melanoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of talimogene laherparepvec (TVEC) therapy for patients with melanoma that cannot be surgically removed (unresectable). The study found that TVEC therapy is an effective treatment for these patients, with minimal side effects. Some background Patients with localized melanoma that is...

Read More

T-VEC treatment in patients with melanoma

Posted by on Feb 9, 2019 in Melanoma | 0 comments

In a nutshell This study wanted to find out how well a new cancer treatment called T-VEC works in patients with melanoma that cannot be surgically removed. The study found that this treatment is very effective in patients with melanoma that cannot be surgically removed. Some background T-VEC is short for talimogene laherparepvec. This is a new type of...

Read More

Association of side effects and response to treatment in patients with melanoma treated with nivolumab

Posted by on Dec 27, 2018 in Melanoma | 0 comments

In a nutshell This study wanted to find out if patients with melanoma who had immune system side effects after treatment with nivolumab (Opdivo) had better outcomes than patients without side effects. The study found that the patients who had side effects from using nivolumab ended up with better responses to treatment and...

Read More

Can S100B and lactate dehydrogenase (LDH) levels be used to predict survival in patients with melanoma?

Posted by on Aug 3, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether levels of S100B and lactate dehydrogenase (LDH) in patients with melanoma treated with immunotherapy has any relationship to survival. The study found that increased levels of S100B and LDH were associated with reduced survival in patients with melanoma treated with certain immunotherapies. Some background...

Read More

Does inflammation replacing tumor cells predict survival in patients with melanoma?

Posted by on Jul 23, 2018 in Melanoma | 0 comments

In a nutshell This study investigated if histological regression (HR – replacement of cancer tumor cells by inflammation) can be used to predict the course of disease (prognosis) in patients with stage III (advanced) melanoma. The study found that histological regression was associated with a better prognosis in patients with stage III...

Read More

Promising News in Melanoma From ASCO 2017

Posted by on Sep 28, 2017 in Melanoma | 0 comments

Video information: As part of our coverage from the 2017 American Society of Clinical Oncology annual meeting, Dr. Ryan Sullivan from Massachusetts General Hospital Cancer Center and Harvard Medical School provides a positive update for melanoma patients. Dr. Sullivan shares positive news related to PD-1 inhibitors and other promising advancements...

Read More